Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC)

Autor:	Fautrel, B, Zhu, B, Taylor, P, van de Laar, M, Emery, P, De Leonardis, F, Gaich, C, Nicolay, C, Kadziola, Z, De La Torre, I, Fleischmann, R
Rok vydání:	2018
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______1064::10a04a766df6828f89a83bb55fca7404 https://doi.org/10.1136/annrheumdis-2018-eular.1997 Zobrazit plný text záznamu